• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者中不同的示踪剂和应激源:如何规范临床问题与核心脏病学的答案。

Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.

作者信息

Marzullo P, Sambuceti G, Gimelli A, Giorgetti A, Parodi O

机构信息

CNR Institute of Clinical Physiology, Pisa, Italy.

出版信息

J Nucl Biol Med (1991). 1994 Dec;38(4):566-72.

PMID:7786918
Abstract

The recent introduction of new tracers and stressors has increased the number of combinations of techniques that can be used for the diagnostic and prognostic stratification of patients with coronary artery disease. However, these new techniques still need to be standardized for clinical use. Thallium-201 scintigraphy is at present the most common method to assess transient ischemia and viability in patients. Dynamic exercise and dipyridamole show similar incidence of major cardiac complications and their use can be considered sufficiently safe. Further experimental and multicenter clinical studies are needed for 99mTc-Sestamibi and 99mTc-Teboroxime and for new stressors such as adenosine and dobutamine.

摘要

最近新型示踪剂和应激源的引入增加了可用于冠心病患者诊断和预后分层的技术组合数量。然而,这些新技术仍需进行临床应用标准化。铊-201闪烁扫描术目前是评估患者短暂性缺血和存活能力的最常用方法。动态运动和双嘧达莫显示出相似的严重心脏并发症发生率,其使用可被认为足够安全。对于99m锝-甲氧基异丁基异腈和99m锝-特丁基异腈以及诸如腺苷和多巴酚丁胺等新型应激源,还需要进一步的实验和多中心临床研究。

相似文献

1
Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.冠心病患者中不同的示踪剂和应激源:如何规范临床问题与核心脏病学的答案。
J Nucl Biol Med (1991). 1994 Dec;38(4):566-72.
2
Perfusion imaging in ischemic heart disease.缺血性心脏病中的灌注成像。
Am Fam Physician. 1993 Nov 1;48(6):1071-8.
3
Myocardial perfusion imaging during pharmacologic stress testing.药物负荷试验期间的心肌灌注成像。
Cardiol Clin. 1994 May;12(2):223-45.
4
[Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].[锝-99m-替硼肟心肌闪烁显像:其可行性及诊断可靠性评估。与铊-201及冠状动脉造影的比较]
G Ital Cardiol. 1992 Jul;22(7):795-805.
5
Evaluating coronary artery disease noninvasively--which test for whom?非侵入性评估冠状动脉疾病——该为谁选择何种检测方法?
West J Med. 1994 Aug;161(2):173-80.
6
The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.新型99mTc心肌灌注显像剂:99mTc-甲氧基异丁基异腈和99mTc-替硼酸肟
Circulation. 1991 Sep;84(3 Suppl):I7-21.
7
Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.多巴酚丁胺输注期间(99m)Tc-N-NOET和(201)Tl的心肌摄取。与腺苷负荷试验的比较。
Circulation. 1999 Oct 12;100(15):1653-9. doi: 10.1161/01.cir.100.15.1653.
8
A review of cardiac imaging with sestamibi and teboroxime.
J Nucl Med. 1991 Oct;32(10):2012-22.
9
Tomographic myocardial perfusion imaging with technetium-99m teboroxime during adenosine-induced coronary hyperemia: correlation with thallium-201 imaging.
J Am Coll Cardiol. 1992 Feb;19(2):307-12. doi: 10.1016/0735-1097(92)90483-4.
10
Measurement of myocardial blood flow by radiolabeled tracers.用放射性示踪剂测量心肌血流量。
J Nucl Med. 1993 Sep;34(9):1518-9.